"Ask Me Anything": Ten Answers To Your Questions About ADHD Medication Pregnancy
From Shiapedia
ADHD Medication During Pregnancy and Breastfeeding
Women with ADHD must make a difficult decision on whether to keep or stop taking ADHD medication for adhd and anxiety in adults during pregnancy and breastfeeding. There aren't enough data on how exposure to ADHD for a long time could affect a pregnant fetus.
A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are required.
Risk/Benefit Analysis
Pregnant women who use ADHD medications need to balance the benefits of using them against the risks to the fetus. Physicians don't have the information needed to make unequivocal recommendations but they can provide information about risks and benefits that aid pregnant women in making informed decisions.
A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers conducted a massive population-based case control study to examine the prevalence of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to confirm that the classification was accurate and to eliminate any bias.
The study conducted by the researchers was not without its limitations. In particular, they were unable to separate the effects of the medication from the disorder that is underlying. This makes it difficult for researchers to establish whether the few associations observed between the groups that were exposed to the use of medication or affected by the presence of comorbidities. Additionally the researchers did not study the long-term outcomes of offspring.
The study found that infants whose mother had taken ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers didn't take any medication during pregnancy or quit taking the medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.
Women who took stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases did not seem to be influenced by the kind of medication used during pregnancy.
The researchers suggest that the risk of a small amount with the use of ADHD medications during early pregnancy could be offset by the higher benefit to both mother and child of continuing treatment for the woman's condition. Doctors should discuss with their patients about this issue and, if possible, help them develop coping strategies that could reduce the impact of her disorder in her daily life and relationships.
Interactions with Medication
Doctors are increasingly confronted with the dilemma of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and reliable evidence. Instead, physicians must take into account their own experience in conjunction with the experiences of other doctors and the research that has been conducted on the subject.
The issue of potential risks to infants is particularly tricky. Many of the studies on this subject are based on observational evidence rather than controlled research and their conclusions are often contradictory. most common adhd medication uk (click through the following page) studies focus on live births, which can underestimate the severity of teratogenic effects which can cause terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these limitations by analyzing both data on live and deceased births.
The conclusion The conclusion: While certain studies have demonstrated that there is a positive correlation between ADHD medications and the risk of certain birth defects, other studies have not found any evidence of a link and the majority of studies demonstrate a neutral or slightly negative effect. In the end an accurate risk-benefit analysis must be done in each case.
It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In fact, in a recent article in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping adhd non stimulant medication uk medication during pregnancy can cause depression, feelings of loneliness, and family conflict for these patients. Additionally, the loss of medication can interfere with the ability to perform jobs and drive safely that are crucial aspects of daily life for many people suffering from ADHD.
She suggests women who are uncertain about whether or not to stop taking medication because of their pregnancy should consider educating family members, friends and colleagues about the condition, its impact on daily functioning, and on the advantages of continuing the current treatment regimen. It can also help women feel supported in her decision. It is important to remember that certain medications are able to be absorbed through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the medication could be transferred to the child.
Birth Defects and Risk of
As the use and use of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (starting adhd medication adults) is increasing as does the concern about the potential effects of these drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Utilizing two huge data sets researchers were able look at more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Although the risk overall is low, the researchers discovered that the first-trimester exposure to ADHD medications was linked to an increase in the risk of certain heart defects, like ventriculo-septal defects (VSD).
The researchers behind the study found no connection between early use of medication and other congenital anomalies, like facial clefting, or club foot. The results are consistent with previous studies showing a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. The risk was higher in the latter half of pregnancy, as many women decide to stop taking their medication.
Women who used ADHD medications during the first trimester of pregnancy were also more likely to have caesarean sections, a low Apgar score after delivery and a baby who required help breathing at birth. However the authors of the study were not able to eliminate bias due to selection by restricting the study to women who didn't have any other medical issues that could have contributed to these findings.
Researchers hope their research will inform physicians when they see pregnant women. They suggest that although discussing risks and benefits is important however, the decision to stop or continue treatment must be based on each woman's needs and the severity of her ADHD symptoms.
The authors caution that, while stopping the medication is a possibility to consider, it is not advised because of the high incidence of depression and mental health issues among women who are pregnant or recently gave birth. Research has also shown that women who stop taking their medications will have a harder time adjusting to a life without them after the baby is born.
Nursing
The responsibilities of a new mother can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments and getting ready for the arrival of a child and adapting to new routines in the home are often faced with a number of difficulties. Many women decide to continue taking their ADHD medication during pregnancy.
The risk to breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk at a low level. However, the rate of medication exposure to the infant can differ based on dosage, frequency it is administered, and the time of day the medication is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn is not well known.
Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the absence of research. It's a difficult choice for the woman who must weigh the benefits of continuing her medication against the risks to the fetus. As long as there is no more information, doctors should ask all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal time.
A increasing number of studies have shown that women can continue their ADHD medication while they are pregnant and nursing. In the end, many patients are choosing to do so and, in consultation with their physician, they have discovered that the benefits of maintaining their current medication far exceed any risk.
Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor, and over the counter adhd medication uk pros and cons of continuing treatment. This includes non stimulant adhd medication uk-pharmacological strategies. Psychoeducation is also required to help pregnant people with ADHD understand their symptoms and the underlying disorder Learn about the available treatments and to reinforce existing strategies for coping. This should be a multidisciplinary process together with obstetricians, GPs, and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, monitoring of signs of deterioration and, if necessary modifications to the medication regime.
